Literature DB >> 10940556

Identification and molecular analysis of BANP.

A Birot1, L Duret, L Bartholin, B Santalucia, I Tigaud, J Magaud, J Rouault.   

Abstract

BTG3 belongs to a family of structurally related genes whose biochemical functions remain elusive. In order to investigate the mechanism underlying BTG3-mediated functions, we tried to identify BTG3 potential partners. The use of the yeast 'two-hybrid system', with BTG3 as bait, enabled us to isolate BANP (BTG3 Associated Nuclear Protein). Other commonly used protein-binding assays did not confirm this yeast interaction. However, BANP had never been described before, and this prompted us to further characterise this gene. In this paper, we present data on its molecular organization in mouse, then we speculate on the nature of this nuclear protein, and finally we localise BANP on the human chromosome 16q24 subregion; we discuss the fact that frequent loss of heterozygosity within this region has been observed in different tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940556     DOI: 10.1016/s0378-1119(00)00244-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.

Authors:  Shravanti Rampalli; L Pavithra; Altaf Bhatt; Tapas K Kundu; Samit Chattopadhyay
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.

Authors:  Kiran Kumar Nakka; Nidhi Chaudhary; Shruti Joshi; Jyotsna Bhat; Kulwant Singh; Subhrangsu Chatterjee; Renu Malhotra; Abhijit De; Manas Kumar Santra; F Jeffrey Dilworth; Samit Chattopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

3.  Banp regulates DNA damage response and chromosome segregation during the cell cycle in zebrafish retina.

Authors:  Swathy Babu; Yuki Takeuchi; Ichiro Masai
Journal:  Elife       Date:  2022-08-09       Impact factor: 8.713

Review 4.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

5.  Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.

Authors:  Debasish Paul; Suvankar Ghorai; U S Dinesh; Praveenkumar Shetty; Samit Chattopadhyay; Manas Kumar Santra
Journal:  Cell Death Dis       Date:  2017-06-15       Impact factor: 8.469

6.  SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.

Authors:  Aftab Alam; Nandaraj Taye; Sonal Patel; Milind Thube; Jayati Mullick; Vibhuti Kumar Shah; Richa Pant; Tanaya Roychowdhury; Nilanjan Banerjee; Subhrangsu Chatterjee; Rittwika Bhattacharya; Rini Roy; Ashis Mukhopadhyay; Devraj Mogare; Samit Chattopadhyay
Journal:  Neoplasia       Date:  2019-08-15       Impact factor: 5.715

7.  Overexpression of SMAR1 Enhances Radiosensitivity in Human Breast Cancer Cell Line MCF7 via Activation of p53 Signaling Pathway.

Authors:  Heng-chao Liu; Fang Ma; Yong Shen; Yong-quan Hu; Shaojun Pan
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

8.  Identity-by-descent detection across 487,409 British samples reveals fine scale population structure and ultra-rare variant associations.

Authors:  Juba Nait Saada; Georgios Kalantzis; Derek Shyr; Fergus Cooper; Martin Robinson; Alexander Gusev; Pier Francesco Palamara
Journal:  Nat Commun       Date:  2020-11-30       Impact factor: 14.919

9.  p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.

Authors:  Kamini Singh; Devraj Mogare; Ramprasad Obula Giridharagopalan; Rajinikanth Gogiraju; Gopal Pande; Samit Chattopadhyay
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

10.  Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer.

Authors:  Ruo-Kai Lin; Wan-Yu Hung; Yu-Fang Huang; Yu-Jia Chang; Chien-Hsing Lin; Wei-Yu Chen; Shih-Feng Chiu; Shih-Ching Chang; Shih-Feng Tsai
Journal:  Oncotarget       Date:  2017-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.